The firm was recognized for its work with Eli Lilly & Company in connection with its acquisition of Novartis Animal Health. It marks Cadwalader's second Matter of the Year win in a row.
Cadwalader represented Salix Pharmaceuticals in its acquisition by Valeant Pharmaceuticals International for $173 per share, or a total enterprise value of approximately $15.6 billion.
Operating from the firm’s Brussels and London offices, Brophy specializes in EU competition law, with expertise in cartel investigations and a growing emphasis on follow-on litigation.
Leading practitioner to combine his energy transactional experience with the firm’s regulatory, financial, corporate and other strengths to serve clients.
The firm’s representation of TutorGroup Holding in securing Series B financing from Alibaba was recognized as the publication’s top deal of 2014.
Firm client Deutsche Bank was recognized for its work in the Ares XXX CLO, which was named “CLO of the Year” at the 4th Annual Investors' Conference on CLOs and Leveraged Loans Conference.
Tompkins led numerous high-profile, complex criminal and civil investigations during her tenure; addition builds upon the momentum of the Firm’s White Collar Defense and Investigations Practice.
The firm has been selected to the New York Law Journal “Diversity Initiative 2015,” which recognizes law firms and legal organizations for their commitment to creating a diverse legal community.